Evidence map›Paper›PMID 27480173›Full record

ArticleGastroenterology2016

Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.

Stephanie N Spohn, Francesca Bianco, Rachel B Scott, Catherine M Keenan, Alisha A Linton, Conor H O'Neill, Elena Bonora, Michael Dicay, Brigitte Lavoie, Rebecca L Wilcox and 4 more

Open access · greenAbstract read
In one paragraph

Article in Gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Serotonin transporter SERT: a novel immune checkpoint for CD8Journal for immunotherapy of cancer · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Novel 5-HTAmerican journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Stephanie N SpohnNeurological Sciences, University of Vermont, Burlington, Vermont.
Francesca BiancoDepartment of Veterinary Medical Sciences, University of Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Rachel B ScottSurgery, Danbury Hospital, Danbury, Connecticut.
Catherine M KeenanHotchkiss Brain Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada; Snyder Institute for Chronic Diseases, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Alisha A LintonNeurological Sciences, University of Vermont, Burlington, Vermont.
Conor H O'NeillSurgery, University of Vermont, Burlington, Vermont.
Elena BonoraDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Michael DicaySnyder Institute for Chronic Diseases, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Brigitte LavoieNeurological Sciences, University of Vermont, Burlington, Vermont.
Rebecca L WilcoxPathology, University of Vermont, Burlington, Vermont.
Wallace K MacNaughtonSnyder Institute for Chronic Diseases, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Roberto De GiorgioDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Keith A SharkeyHotchkiss Brain Institute, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada; Snyder Institute for Chronic Diseases, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Gary M MaweNeurological Sciences, University of Vermont, Burlington, Vermont. Electronic address: gary.mawe@uvm.edu.
University of Vermont · USUniversity of Calgary · CAUniversity of Bologna · ITDanbury Hospital · US

Funding

Proteomics Core for Neuroscience P20 RR16435P20RR016435 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI SPEES, JEFFREY L · 2001 to 2010
$23.5M
Center for Neuroscience ExcellenceP30GM103498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2012 to 2015
$4.3M
Neuronal Excitability and Motility in ColitisR01DK062267 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MAWE, GARY M · 2002 to 2016
$3.3M
CIHRNCRR NIH HHS P20 RR016435NIDDK NIH HHS R01 DK062267NIGMS NIH HHS P30 GM103498
6 · The paper itself

Abstract

BACKGROUND &

aimsThe 5-hydroxytryptamine receptor 4 (5-HT

methodsThe 5-HT

resultsRectal administration of tegaserod reduced the severity of colitis compared with mice given vehicle, and accelerated recovery from active colitis. Rectal tegaserod did not improve colitis in 5-HT

conclusions5-HT

Indexed as

Administration, RectalAnimalsColitisColonDextran SulfateFemaleGuinea PigsIndolesIntestinal MucosaMaleMiceMice, KnockoutReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AgonistsSerotonin 5-HT4 Receptor AntagonistsSeverity of Illness IndexDextran SulfateGR 113808IndolesReceptors, Serotonin, 5-HT4Serotonin 5-HT4 Receptor AgonistsSerotonin 5-HT4 Receptor AntagonistsSulfonamidestegaserodTrinitrobenzenesulfonic AcidColonic MotilityIBDMucosal Drug ActionWound Healing

Identifiers

PMID27480173
PMCPMC5159265
OpenAlexW2485997503

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.